Institutional investors hold a majority ownership of AGN through the 90.58% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2013, these large investors purchased a net $8.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 2.7 Million shares of Allergan Inc
PARNASSUS INVESTMENTS Bought 2.4 Million shares of Allergan Inc
CITADEL ADVISORS LLC Bought 1.8 Million shares of Allergan Inc